INDV · Indivior Pharmaceuticals, Inc. · Executive Compensation
$35.71
+0.33 (+0.93%)
At close · Oct 2
Return incl. dividend (before tax)
Market Cap
$4.23B
Shares
118.01M
Volume · Oct 2
1.65M
Avg daily vol (3M)
2.04M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Joe Ciaffoni | Chief Executive Officer | $18,501,214 |
| Pat Barry Chief | Commercial Officer | $4,905,744 |
| Christian Heidbreder | — | $4,182,548 |
| Richard Simkin | — | $4,017,316 |
| Ryan Preblick | Chief Financial Officer | $3,592,393 |
| Jeff Burris | — | $3,521,215 |
| Mark Crossley | — | $3,185,591 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Former Chief | Executive Officer | $3,853,518 |
| Chief Scientific | Officer | $2,506,997 |
| Ryan Preblick | Chief Financial Officer | $2,281,564 |
| Chief Legal | Officer | $1,969,776 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Former Chief | Executive Officer | $4,391,241 |
| Chief Scientific | Officer | $2,852,128 |
| Ryan Preblick | Chief Financial Officer | $2,397,132 |
| Chief Legal | Officer | $2,202,090 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Stuart A. (Tony) Kingsley | non-executive director | Appointed | 2025-06-24 |
| Joe Ciaffoni | CEO | Appointed | 2025-05-08 |
| Barbara Ryan | Chair of the Compensation Committee | Appointed | 2025-03-04 |
| Joseph Ciaffoni | director | Appointed | 2025-03-04 |
| Joseph Ciaffoni | Chief Executive Officer | Appointed | 2025-03-04 |
| Robert Schriesheim | Independent Non-Executive Director | Resigned | 2025-03-04 |
| Daniel Ninivaggi | Chair of the Nomination Committee | Appointed | 2025-03-04 |
| Joe Ciaffoni | Chief Executive Officer | Appointed | 2025-03-04 |